Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantoprazole + Domperidone vs Pantoprazole in GERD
NCT01710462Phase 3Withdrawn
- Sponsor
- Eurofarma
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of domperidone in gastroesophageal reflux disease (GERD), sponsored by Eurofarma. Planned start Aug 2013; status: withdrawn.
02
Drugs
domperidone
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT01710462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01710462.